PROVOLUT
LIVE

Serial Number

99266882

Owner

Exazyme GmbH

Attorney

KATRIN LEWERTOFF

Filing Date

Jul 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PROVOLUT Trademark

Serial Number: 99266882 • Registration: 8290852

PROVOLUT is a trademark filed by Exazyme GmbH on July 3, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Exazyme GmbH (2 trademarks)

Max-Urich-Str. 3
13355 Berlin 13355 , DE

Entity Type: 99

Trademark Details

Filing Date

July 3, 2025

Registration Date

June 9, 2026

Published for Opposition

April 21, 2026

Goods & Services

IT services, namely, IT consulting services relating to the implementation, integration, maintenance, and customization of software for computational biology, protein engineering, and drug design; development, programming and implementation of software for others; hosting services, namely, hosting cloud-based software platforms for computational protein design, molecular simulation, and drug discovery; platform-as-a-service (PaaS) featuring computer software platforms for computational protein engineering, machine-learning-driven protein optimization, and pharmaceutical drug candidate design and analysis; software-as-a-service (SaaS) services featuring software for AI-driven protein design, protein optimization, molecular engineering, and drug discovery; rental of computer software for computational protein design, protein optimization, molecular simulation, and drug development; design and development of computer hardware and software; scientific and technological services, namely, scientific research, computational analysis, and testing in the field of protein engineering, molecular biology, drug discovery, and biotechnology and scientific and technological research in the field of protein design, enzyme engineering, drug development, and precision oncology and design services relating thereto, namely, computational protein design, enzyme design, drug candidate design, and software design for biotechnology applications; industrial research in the field of biotechnology, protein engineering, and industrial enzyme development and industrial design services; quality control of goods and services and authentication in the field of protein and enzyme quality, pharmaceutical drug candidates, and biotechnological products; development of pharmaceutical products; Scientific laboratory services; laboratory research in the field of protein engineering, molecular biology, enzyme optimization, and pharmaceutical drug development; Scientific laboratory services; Computer software consultancy, information and information services in the field of computational biology, protein engineering, drug design, and biotechnology relating to the aforementioned services; all of the aforementioned services, in particular, in the field of synthetic biology, biotechnology, protein technology, molecular sciences and for the design, development and optimization of proteins, enzymes and molecules

Recorded and downloadable media and data, namely, recorded and downloadable datasets comprising protein sequence, structure, and function data for use in biotechnology and pharmaceutical research; Downloadable databases in the field of protein engineering, molecular biology, and drug discovery; Downloadable software for computational protein design, protein engineering, molecular simulation, and optimization of proteins, enzymes, and molecules for pharmaceutical and industrial biotechnology applications; Downloadable artificial intelligence software for protein design, protein optimization, drug candidate identification, and prediction of protein properties and downloadable software using machine learning for designing, analyzing, optimizing, and predicting the function and properties of proteins, enzymes, and molecules for use in pharmaceutical development and biotechnology; all the aforesaid goods relating to, in particular, synthetic biology, biotechnology, protein engineering, molecular sciences and the design, development and optimization of proteins, enzymes and molecules

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 9, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 9, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 24, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 3, 2025 MAFR
NEW APPLICATION ENTERED
Jul 3, 2025 NWAP